tradingkey.logo
tradingkey.logo
Search

Sol Gel Technologies Ltd

SLGL
Add to Watchlist
82.250USD
-2.940-3.45%
Close 07-31 16:00ETQuotes delayed by 15 min
268.87MMarket Cap
LossP/E TTM

Sol Gel Technologies Ltd

82.250
-2.940-3.45%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-3.45%

5 Days

+0.35%

1 Month

+11.13%

6 Months

+27.51%

Year to Date

+95.18%

1 Year

+532.69%

Key Figures
86.520Open
90.400High
74.06KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.27%Turnover Ratio
85.190Prev. Close
82.250Low
2.89MTurnover
LossP/E Static
5.23P/B
0.00%Div Yield TTM
-18.63%ROA
97.97052wk High
1.37Volume Ratio
-10.58MNet Profit
3.27MShares
-2.1993EPS TTM
1.15Beta
-23.72%ROE
6.80052wk Low
9.57%Amplitude
100.00%Gross Margin
268.87MMarket Cap
2.34Reward/Risk
6.39%Risk Rate

Key Insights

Sol Gel Technologies Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 109 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 193.00.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sol Gel Technologies Ltd's Score

Industry at a Glance

Industry Ranking
109 / 385
Overall Ranking
192 / 4281
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive+

Sol Gel Technologies Ltd Highlights

StrengthsRisks
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 1147.62% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 19.39M.
Undervalued
The company’s latest PE is -37.40, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.00M shares, decreasing 14.87% quarter-over-quarter.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
193.000
Target Price
+134.65%
Upside Space

Sol Gel Technologies Ltd News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 4 analysts
Buy
Current Rating
193.000
Target Price
+134.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Sol Gel Technologies Ltd
SLGL
4
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99

Indicators

Indicators
Sell(2)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.302
Buy
RSI(14)
54.293
Neutral
STOCH(KDJ)(9,3,3)
36.889
Neutral
ATR(14)
6.775
High Vlolatility
CCI(14)
81.984
Neutral
Williams %R
53.529
Neutral
TRIX(12,20)
0.512
Sell
StochRSI(14)
25.764
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
82.577
Sell
MA10
82.954
Sell
MA20
79.748
Buy
MA50
75.997
Buy
MA100
75.597
Buy
MA200
64.156
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Sol Gel Technologies Ltd Info

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Ticker SymbolSLGL
CompanySol Gel Technologies Ltd
CEO
Websitehttp://www.sol-gel.com

Shareholders

Shareholders
Shareholders
Proportion
M.Arkin Dermatology, Ltd.
55.68%
Opaleye Management Inc.
14.18%
Great Point Partners, LLC
8.45%
Phoenix Investment and Finances Ltd
6.50%
Arkin (Moshe)
4.41%
Other
10.77%

FAQs

What is the current price of Sol Gel Technologies Ltd (SLGL)?

The current price of Sol Gel Technologies Ltd (SLGL) is 82.25.

What is the symbol of Sol Gel Technologies Ltd?

The ticker symbol of Sol Gel Technologies Ltd is SLGL.

What is the 52-week high of Sol Gel Technologies Ltd?

The 52-week high of Sol Gel Technologies Ltd is 97.97.

What is the 52-week low of Sol Gel Technologies Ltd?

The 52-week low of Sol Gel Technologies Ltd is 6.80.

What is the market capitalization of Sol Gel Technologies Ltd?

The market capitalization of Sol Gel Technologies Ltd is 268.87M.

Is Sol Gel Technologies Ltd (SLGL) currently rated as Buy, Hold, or Sell?

According to analysts, Sol Gel Technologies Ltd (SLGL) has an overall rating of Buy, with a price target of 193.00.

What is the Earnings Per Share (EPS TTM) of Sol Gel Technologies Ltd (SLGL)?

The Earnings Per Share (EPS TTM) of Sol Gel Technologies Ltd (SLGL) is -2.20.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.